Elsevier’s ‘Hive Project’ to promote drug discovery
As a significant amount of drug discoveries occur outside of pharma companies, Elsevier has launched The Hive Project to promote innovation in the market – outside its walls.
Archives for May 1, 2016
French regulators lift manufacturing ban at Catalent softgel plant
Full production at Catalent’s Beinheim softgel plant has begun five months after the discovery of out-of-place capsules led to French regulators suspending operations.
Xellia and US FDA agree to modified consent decree at ex-Ben Venue site
The US FDA has modified a 2013 consent decree issued to Ben Venue Laboratories, paving the way for new owners Xellia Pharmaceuticals to resume manufacturing at the dormant Ohio site.
Manufacturers concede on price as drug spending increases
Specialty medicine innovation is driving growth, yet advances are being offset by price concessions from manufacturers, according to IMS Health.
Cambrex: delayed API plant opening set for Q2 opening
An API facility Cambrex is setting up in Charles City, Iowa will be operational later than planned due to delayed equipment deliveries and installation challenges.